Hematology Department
Chrysoula Belessi has not added Biography.
If you are Chrysoula Belessi and would like to personalize this page please email our Author Liaison for assistance.
Immunoglobulin heavy- and light-chain repertoire in splenic marginal zone lymphoma.
Molecular medicine (Cambridge, Mass.) Jul-Dec, 2004 | Pubmed ID: 15706403
Analysis of expressed and non-expressed IGK locus rearrangements in chronic lymphocytic leukemia.
Molecular medicine (Cambridge, Mass.) Jan-Dec, 2005 | Pubmed ID: 16622520
IGHV gene insertions and deletions in chronic lymphocytic leukemia: "CLL-biased" deletions in a subset of cases with stereotyped receptors.
European journal of immunology Jul, 2006 | Pubmed ID: 16783849
Activation-induced cytidine deaminase splicing patterns in chronic lymphocytic leukemia.
Blood cells, molecules & diseases Apr, 2010 | Pubmed ID: 20117026
Toll-like receptor signaling pathway in chronic lymphocytic leukemia: distinct gene expression profiles of potential pathogenic significance in specific subsets of patients.
Haematologica Nov, 2011 | Pubmed ID: 21750087
Partial versus productive immunoglobulin heavy locus rearrangements in chronic lymphocytic leukemia: implications for B-cell receptor stereotypy.
Molecular medicine (Cambridge, Mass.) Feb, 2012 | Pubmed ID: 21968789
Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies.
Blood May, 2012 | Pubmed ID: 22415752
Distinct innate immunity pathways to activation and tolerance in subgroups of chronic lymphocytic leukemia with distinct immunoglobulin receptors.
Molecular medicine (Cambridge, Mass.) , 2012 | Pubmed ID: 22437326
Differential microRNA profiles and their functional implications in different immunogenetic subsets of chronic lymphocytic leukemia.
Molecular medicine (Cambridge, Mass.) , 2013 | Pubmed ID: 23615967
IgG-switched CLL has a distinct immunogenetic signature from the common MD variant: ontogenetic implications.
Clinical cancer research : an official journal of the American Association for Cancer Research Jan, 2014 | Pubmed ID: 24240110
Targeted next-generation sequencing in chronic lymphocytic leukemia: a high-throughput yet tailored approach will facilitate implementation in a clinical setting.
Haematologica Mar, 2015 | Pubmed ID: 25480502
Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations.
Blood Jan, 2015 | Pubmed ID: 25634617
Molecular evidence for antigen drive in the natural history of mantle cell lymphoma.
The American journal of pathology Jun, 2015 | Pubmed ID: 25843681
Toll-like receptor stimulation in splenic marginal zone lymphoma can modulate cell signaling, activation and proliferation.
Haematologica Nov, 2015 | Pubmed ID: 26294727
An Immunogenetic Signature of Ongoing Antigen Interactions in Splenic Marginal Zone Lymphoma Expressing IGHV1-2*04 Receptors.
Clinical cancer research : an official journal of the American Association for Cancer Research Apr, 2016 | Pubmed ID: 26647217
Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study.
The Lancet. Haematology Nov, 2014 | Pubmed ID: 27030157
B Cell Anergy Modulated by TLR1/2 and the miR-17∼92 Cluster Underlies the Indolent Clinical Course of Chronic Lymphocytic Leukemia Stereotyped Subset #4.
Journal of immunology (Baltimore, Md. : 1950) 05, 2016 | Pubmed ID: 27059597
Different spectra of recurrent gene mutations in subsets of chronic lymphocytic leukemia harboring stereotyped B-cell receptors.
Haematologica 08, 2016 | Pubmed ID: 27198719
Chronic Lymphocytic Leukemia with Mutated IGHV4-34 Receptors: Shared and Distinct Immunogenetic Features and Clinical Outcomes.
Clinical cancer research : an official journal of the American Association for Cancer Research Sep, 2017 | Pubmed ID: 28536306
No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(immuno)therapy.
Haematologica Apr, 2018 | Pubmed ID: 29269523
Tailored approaches grounded on immunogenetic features for refined prognostication in chronic lymphocytic leukemia.
Haematologica Sep, 2018 | Pubmed ID: 30262567
Integrated epigenomic and transcriptomic analysis reveals TP63 as a novel player in clinically aggressive chronic lymphocytic leukemia.
International journal of cancer Nov, 2018 | Pubmed ID: 30447004
Automated shape-based clustering of 3D immunoglobulin protein structures in chronic lymphocytic leukemia.
BMC bioinformatics Nov, 2018 | Pubmed ID: 30453883
Andreas Agathangelidis*,1,
Lesley Ann Sutton*,2,3,
Anastasia Hadzidimitriou1,
Cristina Tresoldi4,
Anton W. Langerak5,
Chrysoula Belessi6,
Frederic Davi7,
Richard Rosenquist2,3,
Kostas Stamatopoulos1,2,
Paolo Ghia8
1Institute of Applied Biosciences, Centre for Research and Technology Hellas,
2Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University,
3Department of Molecular Medicine and Surgery, Karolinska Institutet,
4Division of Immunology, Transplantation and Infectious, IRCCS San Raffaele Scientific Institute,
5Department of Immunology, Laboratory for Medical Immunology, Erasmus University Medical Center,
6Hematology Department, Nikea General Hospital,
7, Assistance publique - Hôpitaux de Paris (AP-HP), Hopital Pitié-Salpêtrière, Department of Hematology, and UPMC University Paris 06, UMRS 1138,
8Division of Experimental Oncology, IRCCS Istituto Scientifico San Raffaele and Università Vita-Salute San Raffaele
JoVE 소개
Copyright © 2024 MyJoVE Corporation. 판권 소유